NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/17/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.1 mln
Earnings Date11/17/2026
EPS
1,473
Exceptional
P / E
0.00
Anomalous
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-4.54
Highly reliable
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
2.77
Very high leverage
Business Description
Jaguar Health is a San Francisco-based pharmaceutical company that develops plant-derived medicines to treat gastrointestinal conditions in both humans and animals. Its flagship product, Mytesi, is an approved treatment for diarrhea in HIV/AIDS patients, while Canalevia-CA1 addresses the same condition in dogs undergoing chemotherapy. The company is advancing a broader pipeline of treatments targeting conditions such as irritable bowel syndrome, short bowel syndrome, and cancer-related diarrhea across multiple clinical trials.
